When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
TBPMF - Tetra Bio begins additional studies on ARDS-003
Tetra Bio-Pharma Inc
Tetra Bio-Pharma (TBPMF) initiates research projects with Targeted Pharmaceuticals to investigate the potential benefits of ARDS-003 in neuroinflammation and other antiviral applications. The global central nervous system drugs market is expected to grow from $125.28B in 2020 to $163.05B in 2025 at a CAGR of 6%. The partnership with Targeted is expected to provide expertise for expanding the potential Return on Investment of ARDS-003.